The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Effect of the orally available MET inhibitor PF-2341066 on tumor burden and metastasis in an orthotopic xenograft model of bladder cancer.
Maximiliano Sorbellini
No relevant relationships to disclose
Alessio Giubellino
No relevant relationships to disclose
Gaurav Srivastava
No relevant relationships to disclose
Carole Sourbier
No relevant relationships to disclose
Peter A. Pinto
No relevant relationships to disclose
W. Marston Linehan
No relevant relationships to disclose
Donald P. Bottaro
No relevant relationships to disclose